Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 1/20 | 0.54 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.53 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.52 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.52 |
| ▸ | KMO | O15229 | 1/20 | 0.50 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.49 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.49 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.49 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.49 |
| ▸ | SIRT2 | Q8IXJ6 | 4/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2126907 | 0.92 | CYP1A2 (0.60) | CYP1A1CYP1B1CYP1A2HSD17B1HSD17B2 | |
| SCHEMBL18731739 | 0.91 | CYP1A1 (0.66) | CYP1A1CYP1B1CYP1A2HSD17B1HSD17B2 | |
| SCHEMBL14725255 | 0.91 | CYP1A2 (0.50) | CYP1A1CYP1B1CYP1A2HSD17B1HSD17B2 | |
| SCHEMBL27908366 | 0.90 | CYP1A2 (0.58) | CYP1A1CYP1B1CYP1A2CYP11B1CYP11B2 | |
| SCHEMBL23008424 | 0.89 | CYP1A1 (0.64) | CYP1A1CYP1B1CYP1A2KMOCYP11B1 | |
| SCHEMBL30595382 | 0.89 | CYP1A1 (0.59) | CYP1A1CYP1B1CYP1A2HSD17B1HSD17B2 | |
| SCHEMBL25841458 | 0.89 | CYP1A1 (0.59) | CYP1A1CYP1B1CYP1A2HSD17B1HSD17B2 | |
| SCHEMBL22663928 | 0.85 | CYP11B2 (0.68) | CYP1A1CYP1B1KMOCYP11B1CYP11B2 | |
| SCHEMBL30296918 | 0.85 | CYP11B2 (0.68) | CYP1A1CYP1B1KMOCYP11B1CYP11B2 | |
| SCHEMBL22186229 | 0.83 | CYP1A1 (0.61) | CYP1A1CYP1B1CYP1A2HSD17B1HSD17B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240026217-A1 | Light-Emitting Element, Light-Emitting Device, Electronic Device, Lighting Device, and Novel Organic Compound | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2024-01-25 | — | — | US | disclosed |
| US-20240026217-A1 | Light-Emitting Element, Light-Emitting Device, Electronic Device, Lighting Device, and Novel Organic Compound | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2024-01-25 | — | — | US | disclosed |
| US-11773321-B2 | Light-emitting element, light-emitting device, electronic device, lighting device, and novel organic compound | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2023-10-03 | — | — | US | disclosed |
| US-11773321-B2 | Light-emitting element, light-emitting device, electronic device, lighting device, and novel organic compound | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2023-10-03 | — | — | US | disclosed |
| US-20210277305-A1 | Light-Emitting Element, Light-Emitting Device, Electronic Device, Lighting Device, and Novel Organic Compound | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2021-09-09 | — | — | US | disclosed |
| US-11008510-B2 | Light-emitting element, light-emitting device, electronic device, lighting device, and novel organic compound | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2021-05-18 | — | — | US | disclosed |
| US-20170253796-A1 | Light-Emitting Element, Light-Emitting Device, Electronic Device, Lighting Device, and Novel Organic Compound | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2017-09-07 | — | — | US | disclosed |
| US-20170253796-A1 | Light-Emitting Element, Light-Emitting Device, Electronic Device, Lighting Device, and Novel Organic Compound | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2017-09-07 | — | — | US | disclosed |
| US-9663711-B2 | Light-emitting element, light-emitting device, electronic device, lighting device, and novel organic compound | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2017-05-30 | — | — | US | disclosed |
| US-9663711-B2 | Light-emitting element, light-emitting device, electronic device, lighting device, and novel organic compound | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2017-05-30 | — | — | US | disclosed |
| US-20130048964-A1 | Light-Emitting Element, Light-Emitting Device, Electronic Device, Lighting Device, and Novel Organic Compound | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2013-02-28 | — | — | US | disclosed |
| US-20130048964-A1 | Light-Emitting Element, Light-Emitting Device, Electronic Device, Lighting Device, and Novel Organic Compound | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2013-02-28 | — | — | US | disclosed |
| WO-2013027846-A1 | LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE, LIGHTING DEVICE, AND NOVEL ORGANIC COMPOUND | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2013-02-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130048964-A1 | Light-Emitting Element, Light-Emitting Device, Electronic Device, Lighting Device, and Novel Organic Compound | LAGE3, LEF1, PUM2 | CYP1A1 2839/4885CYP1B1 3116/4885CYP1A2 1805/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.